Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patients With Refractory Cirrhotic Ascites [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating the efficacy and safety of dapagliflozin in patients with refractory cirrhotic ascites. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Mansoura University | Conditions: Refractory Ascites | Phase 2 | Status: NOT_YET_RECRUITING